Interferon alfa (Roferon-A®, Viraferon®) – In combination with ribavirin for Hepatitis C, and for Hepatitis B – as per NICE 75 and CG 165

Drug Name (Brand)	Interferon alfa *(Roferon-A®, Viraferon®)*
Indication	In combination with ribavirin for Hepatitis C, and for Hepatitis B – as per NICE 75 and CG 165
Traffic Light Classification	Red
NICE TA	TA75 – Sept 2010
Further Information: NICE recommendations, summary of meeting discussions, links to additional supporting docs etc. April 2013: NHS England SCG took over commissioning responsibility for this treatment. May 2018: This treatment is NHS England commissioning responsibility. Noted by the TAG and recommended to be added to the TAG’s database in line with the Norfolk and Waveney CCGs’ Combined Commissioned Drug Therapies List (March 2018)
Date of TAG recommendation / ratification		11/1/2007	Review Date	1/4/2027